Palohalt

Palohalt

palonosetron

Manufacturer:

MSN

Distributor:

Maxxcare

Marketer:

Mega Lifesciences
Concise Prescribing Info
Contents
Palonosetron HCl
Indications/Uses
Prevention of acute nausea & vomiting associated w/ highly or moderately emetogenic cancer chemotherapy in adults.
Dosage/Direction for Use
IV Adult >18 yr 250 mcg as single dose inj over 30 sec 30 min prior to treatment.
Contraindications
Special Precautions
Patients w/ or family history of QT prolongation, electrolyte abnormalities, CHF, bradyarrhythmias, conduction disturbances. Monitor patients w/ history of constipation or signs of subacute intestinal obstruction. Correct hypokalemia & hypomagnesemia prior to administration. Caution when driving or operating machines. End stage renal disease undergoing haemodialysis. Not to be used in pregnancy. Lactation. Childn.
Adverse Reactions
Headache, dizziness; constipation, diarrhoea.
MIMS Class
Antiemetics / Supportive Care Therapy
ATC Classification
A04AA05 - palonosetron ; Belongs to the class of serotonin (5HT3) antagonists. Used for the prevention of nausea and vomiting.
Presentation/Packing
Form
Palohalt 0.25 mg/5 mL soln for inj
Packing/Price
1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in